Literature DB >> 14627319

Severe reversible cardiomyopathy in four unrelated infants associated with mitochondrial DNA D-loop heteroplasmy.

R G Boles1, C Luna, M Ito.   

Abstract

Inherited disorders of energy metabolism are increasingly being recognized as important causes of cardiomyopathy in children. We previously reported that heteroplasmic point substitutions in the mitochondrial DNA D-loop were found in 15 of 75 children at risk for mitochondrial disease (vs 0/95 controls). Four of these cases presented with severe cardiomyopathy in congestive failure in addition to other anomalies and are presented here. In each case, myocardial dysfunction greatly improved following supportive therapy aimed at reversing both congestive failure and catabolism. D-loop point heteroplasmy may be a marker for severe, reversible, infantile multisystem disease that can present with cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627319     DOI: 10.1007/s00246-002-0263-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

Review 1.  Clinical approach to genetic cardiomyopathy in children.

Authors:  M L Schwartz; G F Cox; A E Lin; M S Korson; A Perez-Atayde; R V Lacro; S E Lipshultz
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

2.  Clinical course of idiopathic dilated cardiomyopathy in children.

Authors:  R A Friedman; J P Moak; A Garson
Journal:  J Am Coll Cardiol       Date:  1991-07       Impact factor: 24.094

Review 3.  Recognition and management of fatty acid oxidation defects: a series of 107 patients.

Authors:  J M Saudubray; D Martin; P de Lonlay; G Touati; F Poggi-Travert; D Bonnet; P Jouvet; M Boutron; A Slama; C Vianey-Saban; J P Bonnefont; D Rabier; P Kamoun; M Brivet
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

4.  Screening for mitochondrial DNA heteroplasmy in children at risk for mitochondrial disease.

Authors:  M Ito; S Tran Le; D Chaudhari; T Higashimoto; A Maslim; R G Boles
Journal:  Mitochondrion       Date:  2001-10       Impact factor: 4.160

5.  Efficiency of metabolic screening in childhood cardiomyopathies.

Authors:  D Bonnet; P de Lonlay; I Gautier; P Rustin; A Rötig; J Kachaner; P Acar; J LeBidois; A Munnich; D Sidi
Journal:  Eur Heart J       Date:  1998-05       Impact factor: 29.983

6.  Outcome of infants and children with dilated cardiomyopathy.

Authors:  A B Lewis; M Chabot
Journal:  Am J Cardiol       Date:  1991-08-01       Impact factor: 2.778

Review 7.  Mitochondria and heart disease.

Authors:  S DiMauro; M Hirano
Journal:  Curr Opin Cardiol       Date:  1998-05       Impact factor: 2.161

8.  Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; R Fasani; M Grasso; P Morbini; N Banchieri; O Bellini; B Dal Bello; A Pilotto; G Magrini; C Campana; P Fortina; A Gavazzi; J Narula; M Viganò
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

  8 in total
  2 in total

1.  Development and initial characterization of xenomitochondrial mice.

Authors:  I A Trounce; M McKenzie; C A Cassar; C A Ingraham; C A Lerner; D A Dunn; C L Donegan; K Takeda; W K Pogozelski; R L Howell; C A Pinkert
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

2.  The mitochondrial genome sequence of Mus terricolor: comparison with Mus musculus domesticus and implications for xenomitochondrial mouse modeling.

Authors:  Wendy K Pogozelski; Leah D Fletcher; Carolyn A Cassar; David A Dunn; Ian A Trounce; Carl A Pinkert
Journal:  Gene       Date:  2008-04-10       Impact factor: 3.688

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.